Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Viking Thera (VKTX)

Viking Thera (VKTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 5,740,068
  • Shares Outstanding, K 111,436
  • Annual Sales, $ 0 K
  • Annual Income, $ -85,900 K
  • EBIT $ -134 M
  • EBITDA $ -142 M
  • 60-Month Beta 0.89
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 6.47

Options Overview Details

View History
  • Implied Volatility 71.68% ( -6.50%)
  • Historical Volatility 90.89%
  • IV Percentile 2%
  • IV Rank 30.48%
  • IV High 234.70% on 02/16/24
  • IV Low 0.20% on 02/27/24
  • Put/Call Vol Ratio 0.47
  • Today's Volume 6,345
  • Volume Avg (30-Day) 27,473
  • Put/Call OI Ratio 0.30
  • Today's Open Interest 203,633
  • Open Int (30-Day) 215,355

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 14 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate -0.27
  • Number of Estimates 11
  • High Estimate -0.24
  • Low Estimate -0.33
  • Prior Year -0.25
  • Growth Rate Est. (year over year) -8.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
47.65 +4.89%
on 11/18/24
79.10 -36.81%
on 11/04/24
-22.90 (-31.42%)
since 11/01/24
3-Month
47.65 +4.89%
on 11/18/24
81.73 -38.85%
on 10/28/24
-8.41 (-14.40%)
since 09/03/24
52-Week
14.02 +256.49%
on 12/04/23
99.41 -49.72%
on 02/28/24
+36.97 (+284.17%)
since 12/01/23

Most Recent Stories

More News
After Crashing 27% in the Past Month, Is Viking Therapeutics Stock a Bargain Buy Right Now?

There's a growing number of companies entering the weight loss space, focusing on GLP-1 drugs which can be game changers for their businesses. And one of them is Viking Therapeutics (NASDAQ: VKTX), which...

VKTX : 49.25 (-4.39%)
LLY : 813.43 (+1.70%)
GS : 603.35 (+0.27%)
PFE : 25.67 (-0.58%)
2 Disruptive Growth Stocks With Room to Run

The investment landscape has transformed since the presidential election, with small-cap stocks gaining momentum. The Russell 2000 index, which tracks the performance of roughly 2,000 smaller publicly...

STLA : 12.56 (+1.54%)
VKTX : 49.25 (-4.39%)
ACHR : 6.91 (-5.34%)
MS : 131.07 (+0.03%)
JAPSY : 8.3405 (-0.71%)
Here's Yet Another Reason to Buy Viking Therapeutics Stock Like There's No Tomorrow

Viking Therapeutics (NASDAQ: VKTX) is a hot biotech stock thanks to the company's record of reporting good data from its cardiometabolic disease programs, and there's no sign of that reputation being tarnished....

VKTX : 49.25 (-4.39%)
Billionaire Ken Griffin Invested $93 Million of Citadel's Portfolio in a Stock That Could Rocket 105% Higher, According to a Wall Street Analyst

Ken Griffin started the Citadel hedge fund in 1990. It's become so successful that his net worth has risen to a stunning $46 billion.

VKTX : 49.25 (-4.39%)
RILY : 5.39 (-1.64%)
NVO : 110.27 (+1.47%)
MDGL : 316.99 (-0.49%)
LLY : 813.43 (+1.70%)
3 Monster Stocks in the Making

Godzilla and King Kong surely weren't born big. They began small and grew over time to their gargantuan sizes even if the movies don't tell their childhood stories.

VKTX : 49.25 (-4.39%)
CRSP : 52.19 (-5.37%)
SMMT : 17.93 (-3.03%)
Stocks Rally on the Prospects of Trump’s Business-Friendly Policies

The S&P 500 Index ($SPX ) (SPY ) Friday closed up +0.35%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.97%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.17%. Stocks on Friday settled...

GOOGL : 171.22 (-0.16%)
INTU : 634.18 (+0.02%)
RDDT : 145.38 (+2.64%)
$SPX : 6,039.83 (-0.12%)
SMCI : 41.24 (-1.81%)
HCA : 327.14 (-0.15%)
NKE : 79.11 (+0.03%)
$IUXX : 21,150.45 (-0.07%)
THC : 141.74 (-0.20%)
QQQ : 515.17 (-0.02%)
ZNH25 : 111-010 (-0.07%)
CPRT : 61.78 (-0.39%)
Stocks Climb on Economic Optimism

The S&P 500 Index ($SPX ) (SPY ) today is up +0.26%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.57%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.04%. Stocks today are moderately higher,...

GOOGL : 171.22 (-0.16%)
INTU : 634.18 (+0.02%)
RDDT : 145.38 (+2.64%)
$SPX : 6,039.83 (-0.12%)
SMCI : 41.24 (-1.81%)
HCA : 327.14 (-0.15%)
NKE : 79.11 (+0.03%)
$IUXX : 21,150.45 (-0.07%)
THC : 141.74 (-0.20%)
QQQ : 515.17 (-0.02%)
ZNH25 : 111-010 (-0.07%)
CPRT : 61.78 (-0.39%)
Stocks Push Higher on Positive Corporate News

The S&P 500 Index ($SPX ) (SPY ) today is up +0.31%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.64%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.11%. Stocks today are moderately higher,...

GOOGL : 171.22 (-0.16%)
INTU : 634.18 (+0.02%)
RDDT : 145.38 (+2.64%)
$SPX : 6,039.83 (-0.12%)
SMCI : 41.24 (-1.81%)
HCA : 327.14 (-0.15%)
NKE : 79.11 (+0.03%)
$IUXX : 21,150.45 (-0.07%)
THC : 141.74 (-0.20%)
QQQ : 515.17 (-0.02%)
ZNH25 : 111-010 (-0.07%)
CPRT : 61.78 (-0.39%)
3 Things You Need to Know if You Buy Viking Therapeutics Today

There aren't many biotechs that are more exciting than Viking Therapeutics (NASDAQ: VKTX) right now. Thanks to its clinical-stage candidate for weight loss, there's a real chance that this competitor could...

VKTX : 49.25 (-4.39%)
Is It Too Late to Buy Viking Therapeutics Stock?

Equity markets have performed well in 2024, but their showing pales next to that of Viking Therapeutics (NASDAQ: VKTX), a mid-cap biotech that rose in prominence this year. The drugmaker's shares are up...

VKTX : 49.25 (-4.39%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Sell with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Viking Therapeutics, Inc. is a biopharmaceutical company. The company is engaged in development of novel therapies for metabolic and endocrine disorders. Its product candidate consists of VK5211, VK0214, VK0612 and VK2809 which are in different clinical trial. Viking Therapeutics, Inc. is based in LA...

See More

Key Turning Points

3rd Resistance Point 54.04
2nd Resistance Point 53.42
1st Resistance Point 52.47
Last Price 49.25
1st Support Level 50.90
2nd Support Level 50.28
3rd Support Level 49.33

See More

52-Week High 99.41
Fibonacci 61.8% 66.79
Fibonacci 50% 56.72
Last Price 49.25
Fibonacci 38.2% 46.64
52-Week Low 14.02

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar